John J Zaunders - JoVE Visualize

Showing results (21-30 of 50) with videos related to

Pageof 5

Sort By:

The Journal of Infection|December 12, 2013

Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapyDenise C Hsu, Stephen J Kerr, Parawee Thongpaeng, et al.

Retrovirology|December 17, 2008

Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infectionWayne B Dyer, John J Zaunders, Fang Fang Yuan, et al.

AIDS (London, England)|March 14, 2012

Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwardsJohn M Murray, Kristin McBride, Christoph Boesecke, et al.

European Journal of Immunology|January 31, 2009

Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration diseaseNabila Seddiki, Sarah C Sasson, Brigitte Santner-Nanan, et al.

Blood|December 3, 2003

Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infectionJohn J Zaunders, Wayne B Dyer, Bin Wang, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|February 27, 2008

Virologic determinants of success after structured treatment interruptions of antiretrovirals in acute HIV-1 infectionSharon R Lewin, John M Murray, Ajantha Solomon, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002

Characterization of CD4(+) CTLs ex vivoVictor Appay, John J Zaunders, Laura Papagno, et al.

AIDS Research and Human Retroviruses|December 5, 2018

HIV-1 DNA Is Maintained in Antigen-Specific CD4+ T Cell Subsets in Patients on Long-Term Antiretroviral Therapy Regardless of Recurrent Antigen ExposureWilliam J Hey-Nguyen, Michelle Bailey, Yin Xu, et al.

Journal of Virology|September 29, 2006

CD127+CCR5+CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cellsJohn J Zaunders, Wayne B Dyer, Mee Ling Munier, et al.

AIDS Research and Human Retroviruses|April 12, 2003

Greater reversal of CD4+ cell abnormalities and viral load reduction after initiation of antiretroviral therapy with zidovudine, lamivudine, and nelfinavir before complete HIV type 1 seroconversionDon E Smith, Gilbert R Kaufmann, James O Kahn, et al.

Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:

Pageof 5

The Journal of Infection|December 12, 2013

Incomplete restoration of Mycobacterium tuberculosis-specific-CD4 T cell responses despite antiretroviral therapyDenise C Hsu, Stephen J Kerr, Parawee Thongpaeng, et al.

Retrovirology|December 17, 2008

Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infectionWayne B Dyer, John J Zaunders, Fang Fang Yuan, et al.

AIDS (London, England)|March 14, 2012

Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwardsJohn M Murray, Kristin McBride, Christoph Boesecke, et al.

European Journal of Immunology|January 31, 2009

Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration diseaseNabila Seddiki, Sarah C Sasson, Brigitte Santner-Nanan, et al.

Blood|December 3, 2003

Identification of circulating antigen-specific CD4+ T lymphocytes with a CCR5+, cytotoxic phenotype in an HIV-1 long-term nonprogressor and in CMV infectionJohn J Zaunders, Wayne B Dyer, Bin Wang, et al.

Journal of Acquired Immune Deficiency Syndromes (1999)|February 27, 2008

Virologic determinants of success after structured treatment interruptions of antiretrovirals in acute HIV-1 infectionSharon R Lewin, John M Murray, Ajantha Solomon, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002

Characterization of CD4(+) CTLs ex vivoVictor Appay, John J Zaunders, Laura Papagno, et al.

AIDS Research and Human Retroviruses|December 5, 2018

HIV-1 DNA Is Maintained in Antigen-Specific CD4+ T Cell Subsets in Patients on Long-Term Antiretroviral Therapy Regardless of Recurrent Antigen ExposureWilliam J Hey-Nguyen, Michelle Bailey, Yin Xu, et al.

Journal of Virology|September 29, 2006

CD127+CCR5+CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cellsJohn J Zaunders, Wayne B Dyer, Mee Ling Munier, et al.

AIDS Research and Human Retroviruses|April 12, 2003

Greater reversal of CD4+ cell abnormalities and viral load reduction after initiation of antiretroviral therapy with zidovudine, lamivudine, and nelfinavir before complete HIV type 1 seroconversionDon E Smith, Gilbert R Kaufmann, James O Kahn, et al.

Pageof 5